Code of Maryland Regulations (Last Updated: April 6, 2021) |
Title 10. Maryland Department of Health |
Part 5. |
Subtitle 62. NATALIE LAPRADE MEDICAL CANNABIS COMMISSION |
Chapter 10.62.15. Medical Cannabis Grower Quality Control |
Sec. 10.62.15.05. Contents of Certificate of Analysis
-
An independent testing laboratory shall issue to the licensed grower a certificate of analysis for each batch, with supporting data, to report:
A. The concentrations of the following compounds:
(1) ∆9-Tetrahydrocannabinol (THC);
(2) Tetrahydrocannabinolic Acid (THCA);
(3) Cannabidiol (CBD);
(4) Cannabidiolic Acid (CBDA); and
(5) The terpenes described in the most current version of the cannabis inflorescence monograph published by the American Herbal Pharmacopeia (AHP);
(6) Cannabigerol (CBG); and
(7) Cannabinol (CBN); and
B. That the presence of the following contaminants does not exceed the levels provided in the Commissions current version of technical authority for medical cannabis testing:
(1) Heavy metals, mercury, lead, cadmium, or arsenic;
(2) Foreign material such as hair, insects, or any similar or related adulterant;
(3) Microbiological impurities such as:
(a) Total aerobic microbial count (TAMC);
(b) Total yeast and mold count (TYMC);
(c) Escherichia coli;
(d) Salmonella spp.;
(e) Aflatoxin B1, B2, G1, and G2; and
(f) Ochratoxin A.; and
(g) Pesticide residue; and
(4) Whether the batch is within specification for the characteristics of:
(a) Odor;
(b) Appearance;
(c) Fineness; and
(d) Moisture content.